WallStreetZenWallStreetZen

NASDAQ: ANEB
Anebulo Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their ANEB stock forecasts and price targets.

Forecast return on equity

Is ANEB forecast to generate an efficient return?
Company
-270.5%
Industry
24.04%
Market
50.12%
ANEB's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ANEB forecast to generate an efficient return on assets?
Company
-224.92%
Industry
10.21%
ANEB is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ANEB earnings per share forecast

What is ANEB's earnings per share in the next 1 years based on estimates from 1 analyst?
Avg 1 year Forecast
-$0.52

ANEB vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ANEB$1.80N/AN/A
ATRA$9.47$24.88+162.67%Hold
RLYB$1.10$10.00+809.09%Buy
ELTX$4.23$10.00+136.41%Buy
RPHM$1.43$1.50+4.90%Hold

Anebulo Pharmaceuticals Stock Forecast FAQ

What is ANEB's earnings growth forecast for 2025-2025?

(NASDAQ: ANEB) Anebulo Pharmaceuticals's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 12%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 29.44%.

Anebulo Pharmaceuticals's earnings in 2024 is -$9,347,314.

In 2025, ANEB is forecast to generate -$13,485,273 in earnings, with the lowest earnings forecast at -$13,485,273 and the highest earnings forecast at -$13,485,273.

If you're new to stock investing, here's how to buy Anebulo Pharmaceuticals stock.

What is ANEB's forecast return on equity (ROE) for 2025-2025?

(NASDAQ: ANEB) forecast ROE is -270.5%, which is considered weak.

What is ANEB's Earnings Per Share (EPS) forecast for 2025-2025?

(NASDAQ: ANEB) Anebulo Pharmaceuticals's current Earnings Per Share (EPS) is -$0.37. In 2025, ANEB's EPS is forecast to hit -$0.52 (min: -$0.52, max: -$0.52).

What is ANEB's forecast return on assets (ROA) for 2025-2025?

(NASDAQ: ANEB) forecast ROA is -224.92%, which is lower than the forecast US Biotechnology industry average of 10.21%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.